2013
DOI: 10.1016/j.placenta.2013.09.010
|View full text |Cite
|
Sign up to set email alerts
|

Contribution of fetal ANXA5 gene promoter polymorphisms to the onset of pre-eclampsia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
44
1
2

Year Published

2016
2016
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 26 publications
(49 citation statements)
references
References 40 publications
2
44
1
2
Order By: Relevance
“…Furthermore, haplotypes for COL4A3 in the mother and for IGF2 and IL2 in the foetus were associated with preterm labour/delivery (25). Similar findings were reported by Ota et al (26) and Roberts and Cooper (27), with these studies demonstrating a foetal-maternal interaction in the aetiology of preeclampsia. In pregnancy the interaction between maternal and foetal genetic backgrounds may also influence a polymorphism-pathology association and increase sPTB susceptibility independently or synergistically.…”
Section: Jnk/casp3 --------------------------------------------------supporting
confidence: 86%
“…Furthermore, haplotypes for COL4A3 in the mother and for IGF2 and IL2 in the foetus were associated with preterm labour/delivery (25). Similar findings were reported by Ota et al (26) and Roberts and Cooper (27), with these studies demonstrating a foetal-maternal interaction in the aetiology of preeclampsia. In pregnancy the interaction between maternal and foetal genetic backgrounds may also influence a polymorphism-pathology association and increase sPTB susceptibility independently or synergistically.…”
Section: Jnk/casp3 --------------------------------------------------supporting
confidence: 86%
“…Available evidence demonstrated that M2 haplotype significantly lowers the expression of ANXA5 in a reporter gene assay [14,16]. The reduction of M2/ANXA5 mRNA [17,18] and its protein levels were further confirmed in thrombophilia-associated placental complication cases [19].…”
Section: Introductionmentioning
confidence: 84%
“…However, the criteria for RPL subjects varied slightly between the studies such as the definition of RPL and categories of embryonic development. In addition to available evidence supporting reduced expression of ANXA5 in chorionic placenta of RPL women, who were M2/ANXA5 carriers [18,19], the male M2/ANXA5 carriers in RPL couples also showed a rather similar risk that would corroborate impeded embryonic anticoagulant function [5,[21][22][23].…”
Section: Introductionmentioning
confidence: 99%
“…It was concluded that the ANXA5 promoter haplotypes may determine the variability of ANXA5 plasma levels in healthy subjects, although additional studies are needed to add clear evidences on clinical influence of circulating annexin A5 levels. In another study, a correlation between the expression levels of ANXA5 in placenta and the M2 haplotype was reported [12].…”
Section: Introductionmentioning
confidence: 92%
“…Two additional SNPs in the ANXA5 promoter have been reported; rs62319820 (c.-628C NT) [11] and rs1050606 (c.-302T NG) [13]. The former SNP has been tightly linked to the M1 haplotype [11], whereas the latter SNP has been suggested as a new risk factor for pregnancy loss in a Japanese population, an association that was found to be independent of the M2 haplotype [12]. Lately, combinations of the M2 haplotype and c.-302G and of the M1 haplotype and the c.-302G and c.-628T SNPs were defined as H3 and H4 haplotypes, respectively [14].…”
Section: Introductionmentioning
confidence: 99%